B-cell proliferation characteristics and monitoring significance under the modified reduced-dose rituximab regimen for NMOSD: A real-world case series study
- Resource Type
- Article
- Source
- In
Multiple Sclerosis and Related Disorders February 2023 70 - Subject
- Language
- ISSN
- 2211-0348